India urges TRIPs flexibility at the WTO to aid access to COVID-19 medicines. CNIPA announces its first COVID-19 vaccine patent application, and key global patent office initiatives are…
Intellepedia · 15 Jun 2020
The Indian patent office reported 739 applications published and 505 patents granted in a single week, indicating strong recovery in activity levels. This bulletin provides a comprehensive analysis…
Intellepedia · 15 Jun 2020
The Indian Patent Office has reported a marked increase in both patent grants and publications for June 2020. Detailed statistics reveal significant growth across major cities and in…
Intellepedia · 14 Jun 2020
Mr. Gaurav Mishra presented an in-depth session on compulsory licensing in India under the Patents Act at a DST Rajasthan event. The talk covered legal provisions, case studies,…
Intellepedia · 3 Jun 2020
This bulletin provides updates on the COVID-19 patent pool, opposition from leading pharmaceutical companies, and key patent law changes in India and abroad. It includes IPO e-filing developments,…
Intellepedia · 1 Jun 2020
This weekly report examines a marked decrease in Indian patent office activity, with significant drops in both publications and grants. It also presents updated figures for design registrations…
Intellepedia · 1 Jun 2020
The Patent Agent Examination 2020 is postponed until further notice, and the Delhi High Court has stayed certain CGPDTM orders. The Indian Patent Office has extended all deadlines…
Intellepedia · 25 May 2020
This week’s Indian patent statistics reveal a notable 72 percent rise in grants and a substantial increase in published applications. The analysis also covers city-wise contributions and industrial…
Intellepedia · 25 May 2020
Indian patent publications have risen sharply this week, marking a 64.98 percent increase over the previous period. The report provides detailed statistical insights into patent grants, examination reports,…
Intellepedia · 18 May 2020
The post analyses patent law updates relating to COVID-19, including India’s push for TRIPS flexibilities and scrutiny of Gilead’s Remdesvir patent. It also covers the EPO’s stance on…
Intellepedia · 18 May 2020